Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004956724 | SCV005460669 | uncertain significance | Inborn genetic diseases | 2024-11-23 | criteria provided, single submitter | clinical testing | The c.1112C>G (p.A371G) alteration is located in exon 12 (coding exon 12) of the OTOA gene. This alteration results from a C to G substitution at nucleotide position 1112, causing the alanine (A) at amino acid position 371 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |